Search datasets

• Organization: U.S. Department of Health & Human Services

ClinicalTrials.gov is a registry and results database of privately and publicly funded clinical studies conducted around the world. Structured study information is submitted by the sponsor or...

• FILE

• Organization: U.S. Department of Health & Human Services

ClinicalTrials.gov is a registry and results database of privately and publicly funded clinical studies conducted around the world. Structured study information is submitted by the sponsor or...

• Organization: U.S. Department of Health & Human Services
• Dataset Last Updated: July 16, 2025

Provides patients, family members, health care professionals, and members of the public easy access to information on clinical trials for a wide range of diseases and conditions.

• HTML
• HTML
• HTML

• Organization: U.S. Environmental Protection Agency
• Dataset Last Updated: April 15, 2012

These data are from a human study collected under IRB protocol: ClinicalTrials.gov # NCT01874834. This dataset is not publicly accessible because: EPA cannot release personally identifiable...

• Organization: Department of Veterans Affairs
• Dataset Last Updated: November 05, 2026

Identifying information about each study, including citation, PubMed ID, PTSDpubs ID, ClinicalTrials.gov ID, and funding source(s).

• JSON
• XML
• CSV

• Organization: Department of Veterans Affairs
• Dataset Last Updated: September 30, 2026

Identifying information about each study, including citation, PubMed ID, PTSDPubs ID, ClinicalTrials.gov ID, and funding source(s).

• JSON
• XML
• CSV

• Organization: U.S. Department of Health & Human Services

334 study participants in dataset. Extension study of TB PACTS TB-1010, ClinicalTrials.gov NCT00694629 to evaluate higher daily doses of rifapentine (10, 15, and 20 mg/kg).

• Organization: U.S. Department of Health & Human Services

1,002 study participants in dataset. Open label, multicenter, randomized (three arms: DOT (standard control), SAT, SAT with SMS reminders) controlled clinical trial. The trial is conducted in...

• Organization: U.S. Department of Health & Human Services

531 study participants in dataset. Phase 2, multicenter, open-label clinical trial evaluated the antimicrobial activity and safety of rifapentine-containing regimens during the intensive phase of...

• Organization: U.S. Department of Health & Human Services

439 study particpants in dataset. Double-blind, randomized controlled trial evaluates moxifloxacin versus isoniazid in daily treatment during the first two months of treatment with rifampin,...

• Organization: U.S. Department of Health & Human Services

1,075 study participants in dataset. Randomized, clinical trial comparing a once-weekly, rifapentine-based, continuation-phase regimen to twice-weekly, rifampin-based "Denver" regimen, both given...

• Organization: U.S. Department of Health & Human Services

336 study participants in dataset. Placebo-controlled factorial study, randomized to study drug (moxifloxacin vs. ethambutol) and treatment frequency (daily vs. thrice weekly after an initial two...

• Organization: U.S. Department of Health & Human Services

8,593 study participants in dataset. Open-label, multi-center, Phase III clinical trial to compare the effectiveness and tolerability of a three-month (12-dose) regimen of weekly rifapentine and...